Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

in response to

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

dlee38

posted on Apr 06, 2022 06:57AM

So if experimental COVID-19 patients taking apabetalone progressed while in the hospital to ICU, the clinical trial states that the treatment will be administered BID with meals. Are meals served in the ICU? Are patients in the ICU coherent enough and are they awake to be served meals? That is why I am puzzled. And again I thank you for your much-appreciated input. :)